• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group.

作者信息

Cillo Umberto, De Carlis Luciano, Del Gaudio Massimo, De Simone Paolo, Fagiuoli Stefano, Lupo Francesco, Tisone Giuseppe, Volpes Riccardo

机构信息

Hepatobiliary and Liver Transplant Unit, University Hospital of Padua, Padua, Italy.

Department of General Surgery and Transplantation, Niguarda Hospital, Milan, Italy.

出版信息

Hepatol Int. 2021 Jun;15(3):831. doi: 10.1007/s12072-021-10178-7.

DOI:10.1007/s12072-021-10178-7
PMID:33779872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8496663/
Abstract
摘要

相似文献

1
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group.对《成人肝移植受者在现实临床实践中的免疫抑制方案：意大利工作组的共识建议》的勘误
Hepatol Int. 2021 Jun;15(3):831. doi: 10.1007/s12072-021-10178-7.
2
Trends in the use of maintenance immunosuppressive drugs among liver transplant recipients in Taiwan: a nationwide population-based study.
Pharmacoepidemiol Drug Saf. 2016 Jun;25(6):661-7. doi: 10.1002/pds.3964. Epub 2016 Jan 22.
3
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients.国际肝脏移植学会关于肝移植受者免疫抑制的共识声明。
Transplantation. 2018 May;102(5):727-743. doi: 10.1097/TP.0000000000002147.
4
Everolimus-based immunosuppressive regimens in lung transplant recipients: impact on CMV infection.肺移植受者中基于依维莫司的免疫抑制方案：对 CMV 感染的影响。
Antiviral Res. 2015 Jan;113:19-26. doi: 10.1016/j.antiviral.2014.10.016. Epub 2014 Nov 7.
5
Possible impact of immunosuppressive therapy regimens on histopathologic outcomes of abnormal uterine bleeding in solid-organ transplant recipients.免疫抑制治疗方案对实体器官移植受者异常子宫出血的组织病理学结果的可能影响。
Clin Transplant. 2018 Aug;32(8):e13305. doi: 10.1111/ctr.13305. Epub 2018 Jun 15.
6
Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors.根据受者和供者中CYP2C9、CYP2C19和CYP3A5基因多态性制定的中国成年肝移植受者给药方案。
Int J Clin Pharmacol Ther. 2016 Aug;54(8):587-96. doi: 10.5414/CP202490.
7
Comparison of Skin Cancer Incidence in Caucasian and Non-Caucasian Liver Vs. Lung Transplant Recipients: A Tale of Two Regimens.白种人和非白种人肝移植与肺移植受者皮肤癌发病率的比较：两种方案的故事。
Clin Drug Investig. 2019 Feb;39(2):197-203. doi: 10.1007/s40261-018-0732-3.
8
Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients.实体器官移植受者侵袭性真菌感染的诊断、预防和治疗的意大利指南。
Transplant Proc. 2011 Jul-Aug;43(6):2463-71. doi: 10.1016/j.transproceed.2011.06.020.
9
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF).意大利肝脏研究协会（AISF）肝脏移植与妊娠立场文件：肝病学女性小组
Dig Liver Dis. 2016 Aug;48(8):860-8. doi: 10.1016/j.dld.2016.04.009. Epub 2016 May 20.
10
Management of metabolic alterations in adult kidney transplant recipients: A joint position statement of the Italian Society of Nephrology (SIN), the Italian Society for Organ Transplantation (SITO) and the Italian Diabetes Society (SID).成人肾移植受者代谢改变的管理：意大利肾脏病学会（SIN）、意大利器官移植学会（SITO）和意大利糖尿病学会（SID）的联合立场声明。
Nutr Metab Cardiovasc Dis. 2020 Aug 28;30(9):1427-1441. doi: 10.1016/j.numecd.2020.05.004. Epub 2020 May 21.

引用本文的文献

1
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients.意大利有关 SARS-CoV-2 感染移植患者的数据支持肝移植受者中存在器官特异性免疫反应。
Front Immunol. 2023 Jul 3;14:1203854. doi: 10.3389/fimmu.2023.1203854. eCollection 2023.